Status:
COMPLETED
The Interplay Between Obstructive Sleep Apnea Cognitive Dysfunction in Pediatric Patients
Lead Sponsor:
Al-Azhar University
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
5-12 years
Phase:
NA
Brief Summary
Objectives: Determination of the impact of obstructive sleep apnea (OSA) on the cognitive function (CF) and serum tumor necrosis factor-α (TNF-α), interleukin (IL)-6 and 1β levels in children aged 5-1...
Detailed Description
All children aged 5-12 years who attended the outpatient clinics of Otorhinolaryngology and/or Pediatrics with complaints suggestive of OSAS were eligible for evaluation for exclusion and inclusion cr...
Eligibility Criteria
Inclusion
- Children in age range of 5-12 years with mild-to-severe OSAS, free of exclusion criteria were enrolled in the study.
Exclusion
- The presence of craniofacial anomalies
- neurological disorders
- very severe OSAS
- OSAS complicated by complex comorbidities
- residual OSAS following adenotonsillectomy (AT), hypothyroidism, or refusal of the suggested therapeutic plans.
- children who failed or were unable to undergo the cognitive function evaluation and those whose parents refused to undergo polysomnography were also excluded from the study.
Key Trial Info
Start Date :
November 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2021
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT05421403
Start Date
November 7 2020
End Date
June 15 2021
Last Update
June 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar University
Asyut, Egypt